Pembelian

CWBR CohBar retracement completed ! Buy opportunity?

728
CWBR CohBar is developing mitochondria based therapeutics for the treatment of age-related diseases.
So it`s an anti-aging listed companies.
They released positive topline results from an early stage study into CB4211, a drug under development for the treatment of nonalcoholic steatohepatitis, but after a 70% increase, the stock went even lower than before the pump.

WBB Securities upgraded CohBar, Inc. stock to Buy from Speculative Buy with a price target of $5.

On 4/23/2021 Maxim Group brokerage Initiated Coverage with a Buy rating and a price target of $3.00

The Market Cap is only 72.138M

I see a lot of potential in this stock! Do you?

Pernyataan Penyangkalan

Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.